Virtual Screening of FDA-Approved Compounds: Exploring New Alternatives for HIV Treatment.

Authors

Daniela P Martinez, Frederico S Kremer

Published in

ACS omega. Volume 11. Issue 8. Pages 13062-13073. Mar 03, 2026. Epub Feb 18, 2026.

Abstract

Human immunodeficiency virus (HIV) infection remains a significant public health challenge, particularly because of the emergence of drug-resistant strains against the drugs currently used in highly active antiretroviral therapy (HAART). The ongoing search for new molecules with therapeutic potential remains crucial. In this study, a virtual screening approach was employed to identify novel candidates with therapeutic potential for HIV. High-throughput screening (HTS) data were used to train and validate quantitative structure-activity relationship (QSAR) models, which were subsequently applied to screen a library of Food and Drug Administration (FDA) approved molecules. The most promising compounds were further evaluated through molecular docking assays and pharmacokinetic property predictions. This process led to the identification of a set of molecules with the potential for further investigation, demonstrating the effectiveness of this approach in drug discovery and repurposing.

PMID:
41799137
Bibliographic data and abstract were imported from PubMed on 17 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.